Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant
Abstract DSG2, encoding desmoglein-2, is one of the causative genes of arrhythmogenic cardiomyopathy. We previously identified a homozygous DSG2 p.Arg119Ter stop-gain variant in a patient with juvenile-onset cardiomyopathy and advanced biventricular heart failure. However, the pathological significa...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-12-01
|
| Series: | Human Genome Variation |
| Online Access: | https://doi.org/10.1038/s41439-024-00304-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594941565468672 |
|---|---|
| author | Takuya Sumida Shou Ogawa Shuichiro Higo Yuki Kuramoto Ryo Eto Yoshihiko Ikeda Congcong Sun Junjun Li Li Liu Tomoka Tabata Yoshihiro Asano Mikio Shiba Yasuhiro Akazawa Daisuke Nakamura Takafumi Oka Tomohito Ohtani Yasushi Sakata |
| author_facet | Takuya Sumida Shou Ogawa Shuichiro Higo Yuki Kuramoto Ryo Eto Yoshihiko Ikeda Congcong Sun Junjun Li Li Liu Tomoka Tabata Yoshihiro Asano Mikio Shiba Yasuhiro Akazawa Daisuke Nakamura Takafumi Oka Tomohito Ohtani Yasushi Sakata |
| author_sort | Takuya Sumida |
| collection | DOAJ |
| description | Abstract DSG2, encoding desmoglein-2, is one of the causative genes of arrhythmogenic cardiomyopathy. We previously identified a homozygous DSG2 p.Arg119Ter stop-gain variant in a patient with juvenile-onset cardiomyopathy and advanced biventricular heart failure. However, the pathological significance and prevalence of the heterozygous DSG2 p.Arg119Ter variant remains uncertain. Here, we identified four unrelated patients with cardiomyopathy with heterozygous DSG2 p.Arg119Ter variants among 808 patients with nonischemic cardiomyopathy; the allele frequency was 0.0037, which is more than 50-fold greater than that reported in the general Japanese population. These patients were clinically diagnosed with arrhythmogenic right ventricular cardiomyopathy (Pt-1), dilated cardiomyopathy (DCM) after ventricular septum defect closure surgery (Pt-2), DCM (Pt-3), and end-stage hypertrophic cardiomyopathy (Pt-4). The patients also exhibited reduced left ventricular contractile function and varying clinical courses. Genetic analysis identified additional possible causative variants, DSG2 p.Arg292Cys in Pt-1 and BAG3 p.His166SerfsTer6 in Pt-3. Immunohistochemical analysis of endomyocardial biopsy samples revealed that the expression of not only desmoglein-2 but also desmoplakin was markedly reduced. Transmission electron microscopy revealed pale and fragmented desmosomes and widened gaps between intercalated discs in the myocardium. A microforce test using human cardiomyocytes differentiated from induced pluripotent stem cells (iPSC-CMs) demonstrated reduced contractility in iPSC-CMs carrying a heterozygous truncating variant in DSG2. These data suggest that the DSG2 p.Arg119Ter variant is concealed in patients with cardiomyopathy with heart failure, and desmosome impairment may be a latent exacerbating factor of contractile dysfunction and disease progression. |
| format | Article |
| id | doaj-art-e5ddc25ab9ef4fa39bbeb6ada97207ad |
| institution | Kabale University |
| issn | 2054-345X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Human Genome Variation |
| spelling | doaj-art-e5ddc25ab9ef4fa39bbeb6ada97207ad2025-01-19T12:15:44ZengNature Publishing GroupHuman Genome Variation2054-345X2024-12-011111910.1038/s41439-024-00304-wFour cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variantTakuya Sumida0Shou Ogawa1Shuichiro Higo2Yuki Kuramoto3Ryo Eto4Yoshihiko Ikeda5Congcong Sun6Junjun Li7Li Liu8Tomoka Tabata9Yoshihiro Asano10Mikio Shiba11Yasuhiro Akazawa12Daisuke Nakamura13Takafumi Oka14Tomohito Ohtani15Yasushi Sakata16Faculty of Medicine, Osaka UniversityDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Pathology, National Cerebral and Cardiovascular CenterDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicinePhotonics Cell Evaluation Laboratory, Graduate School of Engineering, Osaka UniversityPhotonics Cell Evaluation Laboratory, Graduate School of Engineering, Osaka UniversityDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineDepartment of Cardiovascular Medicine, Osaka University Graduate School of MedicineAbstract DSG2, encoding desmoglein-2, is one of the causative genes of arrhythmogenic cardiomyopathy. We previously identified a homozygous DSG2 p.Arg119Ter stop-gain variant in a patient with juvenile-onset cardiomyopathy and advanced biventricular heart failure. However, the pathological significance and prevalence of the heterozygous DSG2 p.Arg119Ter variant remains uncertain. Here, we identified four unrelated patients with cardiomyopathy with heterozygous DSG2 p.Arg119Ter variants among 808 patients with nonischemic cardiomyopathy; the allele frequency was 0.0037, which is more than 50-fold greater than that reported in the general Japanese population. These patients were clinically diagnosed with arrhythmogenic right ventricular cardiomyopathy (Pt-1), dilated cardiomyopathy (DCM) after ventricular septum defect closure surgery (Pt-2), DCM (Pt-3), and end-stage hypertrophic cardiomyopathy (Pt-4). The patients also exhibited reduced left ventricular contractile function and varying clinical courses. Genetic analysis identified additional possible causative variants, DSG2 p.Arg292Cys in Pt-1 and BAG3 p.His166SerfsTer6 in Pt-3. Immunohistochemical analysis of endomyocardial biopsy samples revealed that the expression of not only desmoglein-2 but also desmoplakin was markedly reduced. Transmission electron microscopy revealed pale and fragmented desmosomes and widened gaps between intercalated discs in the myocardium. A microforce test using human cardiomyocytes differentiated from induced pluripotent stem cells (iPSC-CMs) demonstrated reduced contractility in iPSC-CMs carrying a heterozygous truncating variant in DSG2. These data suggest that the DSG2 p.Arg119Ter variant is concealed in patients with cardiomyopathy with heart failure, and desmosome impairment may be a latent exacerbating factor of contractile dysfunction and disease progression.https://doi.org/10.1038/s41439-024-00304-w |
| spellingShingle | Takuya Sumida Shou Ogawa Shuichiro Higo Yuki Kuramoto Ryo Eto Yoshihiko Ikeda Congcong Sun Junjun Li Li Liu Tomoka Tabata Yoshihiro Asano Mikio Shiba Yasuhiro Akazawa Daisuke Nakamura Takafumi Oka Tomohito Ohtani Yasushi Sakata Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant Human Genome Variation |
| title | Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant |
| title_full | Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant |
| title_fullStr | Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant |
| title_full_unstemmed | Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant |
| title_short | Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant |
| title_sort | four cardiomyopathy patients with a heterozygous dsg2 p arg119ter variant |
| url | https://doi.org/10.1038/s41439-024-00304-w |
| work_keys_str_mv | AT takuyasumida fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT shouogawa fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT shuichirohigo fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT yukikuramoto fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT ryoeto fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT yoshihikoikeda fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT congcongsun fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT junjunli fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT liliu fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT tomokatabata fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT yoshihiroasano fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT mikioshiba fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT yasuhiroakazawa fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT daisukenakamura fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT takafumioka fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT tomohitoohtani fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant AT yasushisakata fourcardiomyopathypatientswithaheterozygousdsg2parg119tervariant |